The role of inhibin in polycystic ovary syndrome

References

• Adams, J, et al, Franks, S, Polson, D. Multifollicular ovaries: clinical and endocrine features and response to pulsatile GnRH. Lancet 1985; ii: 1375–1378
   Google Scholar
• Anderson RA, Groome NP, Baird DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. clinical Endocrinology 1998; 48: 577–584
   PubMed Web of Science ®Google Scholar
• Baker TG, Scrimgeour JB. Development of the gonads in anencephalic human fetuses. Functional Morphology of the Human Ovary, Coutts. MTP Press. 1981, In
   Google Scholar
• Balen AH. Pathogenesis of polycystic ovary syndrome — the enigma unravels?. Lancet 1999; 354: 9183–9183
   Google Scholar
• Balen, AH, et al, Conway, GS, Kaltsas, G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 1995; 10: 2107–2111
   PubMed Web of Science ®Google Scholar
• Brown JB. Pituitary control of ovarian function — concepts derived from gonadotrophin therapy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1978; 18: 47–55
   Google Scholar
• Buckler HM, McLachlan VB, Healy DL, Burger HG. Serum inhibin levels in polycycstic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotrophin administration. Journal of Clinical Endocrinology and Metabolism 1988; 66: 798–803
   Google Scholar
• Goodman AL, Hodgen GD. The ovarian triad of the primate menstrual cycle. Recent Progress in Hormone Research 1983; 39: 1–73
   PubMedGoogle Scholar
• Gosden RG. Biology of Menopause. Academic Press, London 1985
   Google Scholar
• Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger F, Mather J, MacNeilly A. Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1996; 81: 1401–1405
   PubMed Web of Science ®Google Scholar
• Hillier S. Regulation of follicular oestrogen synthesis; a survey of current concepts. Journal of Endocrinology 1981; 89: 3–18
   Google Scholar
• Hillier SG. Regulatory functions for inhibin and activin in human ovaries. Journal of Endocrinology 1991; 131: 171–175
   Google Scholar
• Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley WR, Schneyer AL. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site ELISA. Journal of Clinical Endocrinology and Metabolism 1994; 79: 45–50
   Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, Knight P, Ledger WL. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in vitro fertilization embryo transfer. Clinical Endocrinology 1996a; 45: 741–748
   PubMed Web of Science ®Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, Ledger WL. Early follicular phase pulses of inhibin B are absent in PCOS. Simpsom Symposium Report, Edinburgh, 1996b
   Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, Ledger WL. Predicting the unpredictable: inhibin B is prognostic of unexpected under and over response to gonadotrophin stimulation in IVF. Fertility and Sterility Supplement 1997; S90–S91
   Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. Journal of Clinical Endocrinology and Metabolism 1998; 83: 1730–1735
   PubMed Web of Science ®Google Scholar
• Reddi K, Wicking EJ, Hillier SG, Baird DT. Bioactive FSH and inhibin concentrations during ovulation induction in patients with polycystic ovarian disease. Journal of Endocrinology 1989; 123(Supplement 26)
   Google Scholar
• Roberts V, Barth S, El-Roeiy A, Yen S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1994; 77: 1402–1410
   Google Scholar
• Seifer DB, Lambert-Messerlian G, Gardiner AC, Blazer AS, Berk CA. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertility and Sterility 1997; 67: 11–15
   Google Scholar
• Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowlry WF, Jr, Smith JA, Schoenfeld DA, Hall JA. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2645–2652
   Google Scholar